Search alternatives:
larger decrease » marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
-
1641
-
1642
-
1643
-
1644
-
1645
-
1646
-
1647
-
1648
-
1649
-
1650
-
1651
-
1652
-
1653
Data extracted from included studies for the systematic review and meta-analysis.
Published 2025Subjects: -
1654
Specifications and outcomes of clinical trial studies included in the meta-analysis.
Published 2025Subjects: -
1655
Bivariate analysis results.
Published 2025“…Employing multi-channel sequence analysis, we model various material hardship trajectories and examine their association with mental and physical health. …”
-
1656
Sequence analysis results.
Published 2025“…Employing multi-channel sequence analysis, we model various material hardship trajectories and examine their association with mental and physical health. …”
-
1657
Descriptive analysis.
Published 2025“…Employing multi-channel sequence analysis, we model various material hardship trajectories and examine their association with mental and physical health. …”
-
1658
-
1659
Table2_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.DOCX
Published 2024“…Further, data from sleep questionnaires proved sleep-wake disruption in patients with MASLD. We objectively assessed sleep-wake rhythms in patients with biopsy-proven MASLD (n = 35) and healthy controls (HC, n = 16) using actigraphy 24/7 for 4 weeks. …”
-
1660
Table1_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.DOCX
Published 2024“…Further, data from sleep questionnaires proved sleep-wake disruption in patients with MASLD. We objectively assessed sleep-wake rhythms in patients with biopsy-proven MASLD (n = 35) and healthy controls (HC, n = 16) using actigraphy 24/7 for 4 weeks. …”